Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Growth Factors/Hormones VEGF

Human VEGF-D ELISA Kit (ab233625)

Human VEGF-D ELISA Kit (ab233625)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • One-wash 90 minute protocol
  • Sensitivity: 75.7 pg/ml
  • Range: 348.2 pg/ml - 10000 pg/ml
  • Sample type: Cell culture supernatant, Cit plasma, Hep Plasma, Serum
  • Detection method: Colorimetric
  • Assay type: Sandwich (quantitative)
  • Reacts with: Human

You may also be interested in

Recombinant Human VEGFE protein (ab51001)
Product image
Recombinant human VEGF 165A protein (ab61861)
Product image
Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (ab185238)
Product image
Recombinant human VEGFA protein (Active) (ab155722)

Overview

  • Product name

    Human VEGF-D ELISA Kit
    See all VEGFD kits
  • Detection method

    Colorimetric
  • Precision

    Intra-assay
    Sample n Mean SD CV%
    VEGF-D/serum 5 2.9%
    Inter-assay
    Sample n Mean SD CV%
    VEGF-D/serum 3 2.6%
  • Sample type

    Cell culture supernatant, Serum, Hep Plasma, Cit plasma
  • Assay type

    Sandwich (quantitative)
  • Sensitivity

    75.7 pg/ml
  • Range

    348.2 pg/ml - 10000 pg/ml
  • Recovery

    Sample specific recovery
    Sample type Average % Range
    Serum 88 85% - 92%
    Cell culture media 101 98% - 106%
    Hep Plasma 78 74% - 82%
    Cit plasma 88 84% - 92%
  • Assay time

    1h 30m
  • Assay duration

    One step assay
  • Species reactivity

    Reacts with: Human
  • Product overview

    Human VEGF-D ELISA Kit (ab233625) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of VEGF-D protein in hep plasma, serum, cell culture supernatant, and cit plasma. It uses our proprietary SimpleStep ELISA® technology. Quantitate Human VEGF-D with 75.7 pg/ml sensitivity.


    SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:


            - Single-wash protocol reduces assay time to 90 minutes or less
            - High sensitivity, specificity and reproducibility from superior antibodies
            - Fully validated in biological samples
            - 96-wells plate breakable into 12 x 8 wells strips


    A 384-well SimpleStep ELISA® microplate (ab203359) is available to use as an alternative to the 96-well microplate provided with SimpleStep ELISA® kits.

  • Platform

    Pre-coated microplate (12 x 8 well strips)

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 1 x 96 tests
    10X Human VEGF-D Capture Antibody 1 x 600µl
    10X Human VEGF-D Detector Antibody 1 x 600µl
    10X Wash Buffer PT (ab206977) 1 x 20ml
    Antibody Diluent 5BI 1 x 6ml
    Human VEGF-D Lyophilized Recombinant Protein 2 vials
    Plate Seals 1 unit
    Sample Diluent NS (ab193972) 1 x 50ml
    SimpleStep Pre-Coated 96-Well Microplate (ab206978) 1 unit
    Stop Solution 1 x 12ml
    TMB Development Solution 1 x 12ml
  • Research areas

    • Cardiovascular
    • Angiogenesis
    • Growth Factors
    • VEGF
    • VEGF
    • Signal Transduction
    • Growth Factors/Hormones
    • VEGF
    • Cancer
    • Growth factors
    • VEGF
    • Cancer
    • Invasion/microenvironment
    • Angiogenesis
    • Angiogenic growth factors
  • Function

    Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.
  • Tissue specificity

    Highly expressed in lung, heart, small intestine and fetal lung, and at lower levels in skeletal muscle, colon, and pancreas.
  • Sequence similarities

    Belongs to the PDGF/VEGF growth factor family.
  • Post-translational
    modifications

    Undergoes a complex proteolytic maturation which generates a variety of processed secreted forms with increased activity toward VEGFR-3 and VEGFR-2. VEGF-D first form an antiparallel homodimer linked by disulfide bonds before secretion. The fully processed VEGF-D is composed mostly of two VEGF homology domains (VHDs) bound by non-covalent interactions.
  • Cellular localization

    Secreted.
  • Target information above from: UniProt accession O43915 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Alternative names

    • c-fos induced growth factor
    • c-fos induced growth factor (vascular endothelial growth factor D)
    • c-fos-induced growth factor
    • FIGF
    • Vascular endothelial growth factor D
    • Vascular endothelial growth factor D precursor
    • VEGF D
    • VEGF-D
    • VEGFD
    • VEGFD_HUMAN
    see all
  • Database links

    • Entrez Gene: 2277 Human
    • Omim: 300091 Human
    • SwissProt: O43915 Human
    • Unigene: 11392 Human

    Images

    • Other - Human VEGF-D ELISA Kit (ab233625)
      Other - Human VEGF-D ELISA Kit (ab233625)

      SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.

       

    • Example of human VEGF-D standard curve in Sample Diluent NS
      Example of human VEGF-D standard curve in Sample Diluent NS

      Background-subtracted data values (mean +/- SD) are graphed.

    • Interpolated concentrations of native VEGF-D in human serum and plasma samples
      Interpolated concentrations of native VEGF-D in human serum and plasma samples

      The concentrations of VEGF-D were measured in duplicates, interpolated from the VEGF-D standard curves and corrected for sample dilution. Undiluted samples are as follows: serum neat, plasma (citrate) neat, and plasma (heparin) neat. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean VEGF-D concentration was determined to be 2,105 pg/mL in neat serum, 1,349 pg/mL in neat plasma (citrate) and 1,232 pg/mL in neat plasma (heparin). Native signal is undetectable in RPMI cell culture supernatant containing 10% bovine serum (not shown).

    • Interpolated concentrations of spike VEGF-D in human serum, plasma, and cell culture media samples
      Interpolated concentrations of spike VEGF-D in human serum, plasma, and cell culture media samples

      The concentrations of VEGF-D were measured in duplicates, interpolated from the VEGF-D standard curves and corrected for sample dilution. Undiluted samples are as follows: serum neat, plasma (citrate) neat, plasma (heparin) neat, and RPMI cell culture media containing 10% FBS. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). Native signal is undetectable in RPMI cell culture supernatant containing 10% bovine serum (not shown).

    • Serum from ten individual healthy human female donors was measured in duplicate
      Serum from ten individual healthy human female donors was measured in duplicate

      Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean VEGF-D concentration was determined to be 2,193 pg/mL with a range of 956.9 – 3,270 pg/mL.

    • Sandwich ELISA - Human VEGF-D ELISA Kit (ab233625)
      Sandwich ELISA - Human VEGF-D ELISA Kit (ab233625)
      To learn more about the advantages of recombinant antibodies see here.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Human VEGF-D ELISA Kit (ab233625)

    •  
    • Product image

      Human VEGF-D Antibody Pair - BSA and Azide free (ab244098)

      Applications:

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-FGFR1 Oncogene Partner antibody [EPR9929] (ab156013)

    •  
    • Product image

      Anti-DB1 antibody [ZNF5J141] (ab50970)

    •  
    • Product image

      Anti-CtIP (phospho S738) antibody [EP18893] (ab195291)

    •  
    • Product image

      Anti-CRMP2 (phospho T509) antibody (ab192799)

    •  
    • Product image

      Anti-EBS antibody - N-terminal (ab224439)

    •  
    • Product image

      PE/Cy7® Anti-PD1 antibody [EH12.2H7] (ab270681)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.